Risk Perception and Communication

Slides:



Advertisements
Similar presentations
HEALTHY PEOPLE. Aims  Interpret evidence about a screening programme and decide whether it is worthwhile – for individuals or groups  Demonstrate an.
Advertisements

Breast Cancer Early Detection is Your Best Protection
Health Literacy: how to explain risk? Dr. Keiko Yasukawa University of Technology, Sydney.
†Source: U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2011 Incidence and Mortality Web-based Report. Atlanta (GA): Department.
Screening for Breast and Prostate Cancer: Who Should be Tested? Why the Controversy? Brandon P. Combs, MD GIM Grand Rounds 12 February 2013.
USPSTF Screening Recommendations: Implications for Adults at Higher Risk NYFAHC Roundtable, June 18, 2013 Robert A. Smith, PhD Senior Director, Cancer.
ABCWINRisk and Statistics1 Risk and Statistics Risk Assessment in Clinical Decision Making Ulrich Mansmann Medical Statistics Branch University of Heidelberg.
Breast Cancer Screening
Otis W. Brawley, M.D. Chief Medical and Scientific Officer Executive Vice President American Cancer Society Professor of Hematology, Medical Oncology,
The Facts about Breast Cancer
Geriatric Health Maintenance: Cancer Screening Linda DeCherrie, MD Geriatric Fellow Mount Sinai Hospital.
Health Promotion and Disease Prevention-focus on Cancer Edward Anselm, MD Assistant Professor of Medicine Icahn School of Medicine at Mount Sinai Medical.
Prostate Cancer: Education & Outreach
© Open University Press, 2004 Overview Prevention and screening Psychological predictors of screening The ethics and usefulness of screening? Psychological.
Prostate Cancer Screening 2012 Paul L. Crispen, MD Department of Surgery University of Kentucky.
Number Sense Part II – Computations and Benchmarks.
How to Overcome Barriers and Develop Collaborative Guidelines Amir Qaseem, MD, PhD, MHA, FACP Chair, Guidelines International Network Director, Clinical.
Risk Prediction in Clinical Practice Joann G. Elmore MD, MPH SCCA June 11, 2014.
EPIB-591 Screening Jean-François Boivin 29 September
A/Prof Brian Cox Cancer Epidemiologist Dunedin. Research Associate Professor Brian Cox Hugh Adam Cancer Epidemiology Unit Department of Preventive and.
1/20 Remco Chang (Computer Science) Paul Han (Tufts Medical / Maine Medical) Holly Taylor (Psychology) Improving Health Risk Communication: Designing Visualizations.
Prostate Cancer: A Case for Active Surveillance Philip Kantoff MD Dana-Farber Cancer Institute Professor of Medicine Harvard Medical School.
Routine PSA: Evaluating the Evidence Sheldon Greenfield, MD Health Policy Research Institute University of California, Irvine October 23, 2012.
Prostate Cancer Coalition of North Carolina Prostate Cancer / Breast Cancer Brother / Sister Diseases Your Name PCCNC Women’s Programs Your.
Decision Support as a Clinical Skill Module V: Communicating Risk Information Last update: September 2008.
Prostate Cancer Screening in African American Men Mark H. Kawachi, MD FACS Director, Prostate Cancer Center City of Hope, National Medical Ctr.
An Integrated Approach to Breast Cancer Control A flexible approach that can be adapted to national or local circumstances.
Communicating Numbers to Ensure Patient-Provider Partnership Decisions Health numeracy- Communicating evidence to the patient David L. Hahn, M.D., M.S.
 Volunteer bias  Lead time bias  Length bias  Stage migration bias  Pseudodisease.
Evaluating Screening Programs Dr. Jørn Olsen Epi 200B January 19, 2010.
Prostate Cancer Management: A Guide for Patients and Caregivers
v. # Breast Cancer Update Monita Soni, MD, FCAP-President, PrimePath, PC Decatur, AL CAP Spokesperson November 2010.
Rationalizing the New Healthcare Paradigm Scientific Agenda vs. Patient Imperatives Scientific Agenda vs. Patient Imperatives.
Mammography. Basic Facts About Mammograms Simply put, a mammogram is just an x-ray taken of the breast tissues in the body. Mammograms require that a.
Promoting Patient Involvement in Medication Decisions David H. Hickam, MD, MPH Professor, Dept. of Medicine Oregon Health & Science University Portland,
Discussing numerical data with patients. Framing Framing manipulations: describing equivalent choice situations in different ways Information on relative.
From EBM to SDM: Michel Labrecque MD PhD Michel Cauchon MD Department of Family and Emergency Medicine Université Laval Teaching how to apply evidence.
What are the Chances Dr? Nick Pendleton. Can I have a Prostate Check? ?
Do Decision Aids Promote Shared Decision-Making for Prostate Cancer Screening? Alex Krist MD Steven Woolf MD MPH Robert Johnson PhD Department of Family.
The Elliott Breast Center * Baton Rouge, LA *
From EBM to SDM: Michel Labrecque MD PhD Michel Cauchon MD Department of Family and Emergency Medicine Université Laval Teaching how to apply evidence.
Screening for Prostate Cancer
Aspects of Decisions I Which decision was made? → Outcome
Communicating Risk.
Cancer prevention and early detection
Cancer Screening Guidelines
Risk-adapted prostate cancer (PCa) early detection study based on a “baseline” PSA value in young men – a prospective multicenter randomized trial (PROBASE)
Cancer screening decisions: The role of feelings vs. beliefs
Cancer and the Cell Cycle
Mammograms and Breast Exams: When to start /stop mammograms
Optimal Ways to learn about and communicate Evidence Based Medicine
Principles of Epidemiology E
Who Shall Live? Who Shall Die?
Cancer Screening: Who, When and Why?
New Study Offers Support for Prostate Testing
Definition of Cancer Screening
Cancer Prevention Screening and Early Detection PROF.MAZIN AL-HAWAZ.
2017 USPSTF Draft Recommendations for Prostate Cancer Screening
Cancer screening PROF .MAZIN AL-HAWAZ.
BME 301 Lecture Fourteen.
Prevention and Early Diagnosis of Cancer Ongar Health Centre Patient Forum 7th March 2018 Sue White Cancer Research UK Facilitator.
Prostate Cancer Awareness
Shared Decision-Making
Cognitive Bias Regarding Risks and Benefits
Prostate Cancer Screening- Update
Dr. Hannah Jordan Lecturer in Public Health ScHARR
NEEDS IN COMMUNICATION
Breast Cancer Guideline Update – Sharp Focus on Who is at Risk
Making data provocative and personal
Evidence Based Diagnosis
Presentation transcript:

Risk Perception and Communication The risks that upset people are completely different than the risks that kill people. Peter Sandman Risk Perception and Communication Wolfgang Gaissmaier, PhD Department of Psychology Social Psychology and Decision Sciences

Misperception of risk Statistical information is notoriously difficult to understand Gigerenzer, Gaissmaier, et al (2007). Psychological Science in the Public Interest People fear the wrong things: Flying ↑, Disease progression of MS↓, cardiovascular disease↓ Gaissmaier & Gigerenzer (2012). Psychological Science Heesen, Gaissmaier, et al (2013). PLoS One Oertelt-Prigione, Seeland, Kendel, Rücke, Flöel, Gaissmaier, et al (2015). BMC Medicine Slovic (1987). Science They overestimate the benefits of medical treatments Gigerenzer, Mata, & Frank (2009). JNCI Heesen, Kleiter, Nguyen, Schäffler, Kasper, Köpke, & Gaissmaier (2010). Multiple Sclerosis

3

Ecological Rationality Mind Environment Gigerenzer & Gaissmaier (2011). Annual Review of Psychology

160 Gynecologists estimate: Probability of breast cancer | positive mammogram Estimates (%) Beste Schätzung Before Training Gigerenzer, Gaissmaier, Kurz-Milcke, Schwartz & Woloshin (2007). Psychological Science in the Public Interest

~10 % Mammography 10 cancer 990 no cancer 9 positive 89 1 negative 901 1000 women Natural Frequencies Conditional Probabilities p(breast cancer) = 1% p(positive|cancer) = 90% p(positive|no cancer) = 9% .01 x .90 .01 x .90 + .99 x .09 p(cancer|positive) = p(cancer|positive) = 9 9 + 89 ~10 % Mammography

160 Gynecologists estimate: Probability of breast cancer | positive mammogram Estimates (%) Best Estimate Before Training After Training Gigerenzer, Gaissmaier, Kurz-Milcke, Schwartz & Woloshin (2007). Psychological Science in the Public Interest

“I had prostate cancer, five, six years ago “I had prostate cancer, five, six years ago. My chances of surviving prostate cancer, and thank God I was cured of it, in the United States, 82 percent. My chances of surviving prostate cancer in England, only 44 percent under socialized medicine.” Rudy Giuliani New Hampshire radio advertisement, October 29, 2007

Lead time bias 9

Overdiagnosis bias 10

Wegwarth, Gaissmaier, & Gigerenzer (2010). Medical Decision Making 2 in 1,000 vs. 1.6 in 1,000 68% vs. 99% Wegwarth, Schwartz, Woloshin, Gaissmaier, & Gigerenzer (2012). Annals of Internal Medicine Wegwarth, Gaissmaier, & Gigerenzer (2010). Medical Decision Making

Facts boxes Simple tabular representation Balanced overview of benefits and harms Reducing the information to the most relevant pieces Simulatneous comparison between people with different treatments with treament vs. placebo (pre- vs. post-treatment) Are very well accepted by patients Facilitate comprehension as well as the identification of superior options Schwartz, Woloshin, & Welch (2007) Medical Decision Making Schwartz, Woloshin, & Welch (2009) Annals of Internal Medicine

Prostate Cancer Early Detection by PSA screening and digital-rectal examination. Numbers are for men aged 50 years or older, not participating vs. participating in screening for 13 years. Benefits 1,000 men without screening with How many men died from prostate cancer? 5* 4 How many men died from any cause? 200 200 Harms How many men were diagnosed and treated** for prostate cancer unnecessarily? – 30 How many men without cancer got a false alarm and a biopsy? 170 * This means that about 5 out of 1,000 men (50+ years of age) without screening died from prostate cancer within 13 years. ** With prostate removal or radiation therapy, which can lead to incontinence or impotence. Source: Schröder FH, Hugosson J, Roobol MJ, et al. (2014). The Lancet.

Graphical representations help people digest numbers are preferred reduce the influence of biases such as the ones presented earlier (framing, anecdotes, etc.) support healthy behaviors Gaissmaier et al. (2012) Health Psychology Garcia-Retamero & Cokely (2013) Current Directions in Psychological Science Trevena et al. (2013) BMC Medical Informatics and Decision Making

Prostate Cancer Early Detection by PSA screening and digital-rectal examination. Numbers are for men aged 50 years or older, not participating vs. participating in screening for 10 years. 1,000 men without screening: 1,000 men with screening: P P P P P P P P P X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X Men dying from prostate cancer: Men dying from any cause: Men that were diagnosed and treated for prostate cancer unnecessarily: Men without cancer that got a false alarm and a biopsy: Remaining men 5 200 – 4 200 30 170 P X Source: Schröder FH, Hugosson J, Roobol MJ, et al. (2014). The Lancet.

Conclusions Clinical evidence is notoriously difficult to understand Statistics are an educational blind spot of many people Transparent representations foster insight But: Behavior does not really change Gaissmaier & Gigernzer (2011). Better Doctors, Better Patients, Better Decisions.

Conclusions Lack of evidence culture Ideologies often matter more than evidence How can evidence be made not only understandable, but convincing? Social heuristics: Trust in authorities (e.g., physicians) Authorities may lack understanding Conflicts of interest Defensive decision making When do social heuristics make sense? Gaissmaier & Gigernzer (2011). Better Doctors, Better Patients, Better Decisions.